TL;DR — Long-Term Creatine Safety
Creatine monohydrate has been studied for over 30 years, making it one of the most researched supplements in existence. Long-term studies — including 5+ years of continuous use — consistently show no adverse effects on kidney function, liver function, hormonal profiles, or overall health markers. The ISSN position stand explicitly states that creatine is safe for long-term use at recommended doses of 3-5g/day (RB et al., 2017) . There is no established maximum duration for creatine use, and many researchers and athletes have taken it continuously for decades.
The Evidence for Long-Term Safety
5+ Year Case Studies
Antonio & Ciccone (2013) documented comprehensive health monitoring over 5 years of continuous creatine supplementation. Blood panels including kidney function markers (BUN, creatinine, GFR), liver enzymes (ALT, AST), lipid profiles, and complete blood counts showed no adverse changes attributable to creatine use (J & V, 2013) .
This study is particularly valuable because most creatine studies last 4-12 weeks. The 5-year observation period provides confidence that the safety demonstrated in short-term trials extends to chronic use.
Kidney Function Analysis
Poortmans & Francaux (2000) published one of the most cited studies on creatine and kidney health. Their comprehensive analysis of renal function in long-term creatine users showed no detrimental effects on glomerular filtration rate, tubular reabsorption, or overall kidney function (JR & M, 2000) .
The confusion about creatine and kidneys stems from creatinine — a breakdown product of creatine that is routinely measured in blood tests as a marker of kidney function. When you supplement with creatine, your body produces more creatinine (because there is more creatine to break down). This raises serum creatinine levels, which can falsely suggest impaired kidney function on standard blood tests.
This is a measurement artifact, not actual kidney damage. Doctors can verify kidney function using alternative markers like Cystatin C, which is unaffected by creatine supplementation.
The ISSN Position Stand
The International Society of Sports Nutrition’s 2017 position stand represents the most comprehensive expert review of creatine research ever published. After reviewing hundreds of studies spanning three decades, the panel of experts concluded:
- Creatine monohydrate is safe for healthy individuals at recommended doses
- No scientific evidence supports any detrimental effects from short- or long-term use
- Creatine supplementation poses no greater health risk than common foods like meat and fish
- Long-term supplementation (up to 5 years) has been shown to be safe
Specific Long-Term Safety Concerns Addressed
Kidney Health
The kidney concern is the most persistent myth about creatine supplementation. Here is the complete picture:
Healthy kidneys: No study has ever demonstrated kidney damage from creatine supplementation in healthy individuals at recommended doses. Gualano et al. (2011) specifically examined this question and found no adverse renal effects (B et al., 2011) .
Pre-existing kidney disease: If you have diagnosed kidney disease, consult your nephrologist before supplementing. While creatine has not been shown to cause kidney problems, individuals with existing renal impairment have different considerations. This is a precautionary recommendation, not evidence of harm.
The creatinine confusion: Supplementing with creatine raises serum creatinine by approximately 20-30%. This is normal and expected. If your doctor orders a basic metabolic panel, inform them that you take creatine so they can interpret the results correctly or use Cystatin C as an alternative kidney function marker.
Liver Health
Long-term studies consistently show no adverse effects on liver enzymes (ALT, AST, GGT) from creatine supplementation. The liver plays a role in creatine synthesis, but supplementing with exogenous creatine does not overload hepatic function. If anything, providing creatine exogenously slightly reduces the liver’s workload of synthesising creatine endogenously.
Hormonal Effects
Creatine supplementation does not meaningfully alter testosterone, cortisol, or other hormone levels. An early study suggested creatine might increase DHT (dihydrotestosterone), raising concerns about hair loss, but this finding has not been replicated in subsequent research. The ISSN position stand does not identify hormonal disruption as a concern.
Natural Creatine Production
A common concern is that long-term supplementation might suppress the body’s natural creatine synthesis, similar to how exogenous testosterone can suppress natural production. This does not occur with creatine. The endogenous synthesis pathway (AGAT and GAMT enzymes in the kidneys and liver) is not permanently downregulated by supplementation. When you stop taking creatine, your body resumes normal production within days.
What Happens When You Stop After Years
If you discontinue creatine after long-term use, the process is straightforward and entirely benign:
Days 1-7: No noticeable change. Muscle creatine stores remain elevated.
Weeks 2-3: Stores begin to decline gradually. You may notice a slight reduction in performance during very high-intensity efforts. Weight may decrease by 0.5-1 kg as intracellular water decreases.
Weeks 4-6: Creatine stores return to pre-supplementation baseline levels. All supplementation-related performance benefits are gone. Total water weight loss is typically 1-3 kg.
Beyond 6 weeks: Your body continues producing creatine endogenously at its normal rate (approximately 1-2g/day). There is no rebound effect, no withdrawal, and no lasting changes from years of supplementation.
Importantly, you do not lose muscle tissue from stopping creatine. The actual muscle protein remains intact. What you lose is the intracellular water held alongside creatine in muscle cells and the performance enhancement from elevated phosphocreatine stores.
Malaysian Healthcare Context
In Malaysia, awareness of creatine supplementation among healthcare professionals is growing but still limited. Here are practical considerations:
Blood test interpretation: If you take creatine and undergo routine blood work at any Malaysian hospital or clinic (including government clinics), inform your doctor that you supplement with creatine. Elevated creatinine on a basic metabolic panel may trigger unnecessary concern or referral to a nephrologist. A simple conversation can avoid this.
Government clinic compatibility: The Malaysian National Pharmaceutical Regulatory Agency (NPRA) classifies creatine as a food supplement, not a medication. It is legal and available over the counter.
Insurance considerations: Creatine supplementation does not affect health insurance coverage or medical insurance applications in Malaysia. It is a legal dietary supplement with an excellent safety profile.
Sports medicine doctors: Malaysian sports medicine specialists at institutions like Institut Sukan Negara (National Sports Institute) are well-versed in creatine supplementation and can provide informed guidance for competitive athletes.
Long-Term Cost in Malaysia
For those considering long-term creatine use, here is what the commitment looks like financially:
At 5g/day using a mid-range product (approximately RM60 per 300g tub):
- Monthly cost: ~RM30
- Annual cost: ~RM360
- 5-year cost: ~RM1,800
This is remarkably affordable for a supplement with one of the strongest evidence bases in sports nutrition. For comparison, a daily Starbucks coffee habit in Malaysia costs approximately RM5,400 per year.
The Bottom Line
Creatine monohydrate is safe for long-term, continuous use at recommended doses of 3-5g/day. Over 30 years of research, including studies spanning 5+ years of continuous use, have found no adverse effects on kidneys, liver, hormones, or overall health. The scientific consensus, as expressed by the ISSN and multiple review papers, is clear: take 3-5g daily for as long as you wish to maintain the benefits.
Sources & References
This article cites the ISSN Position Stand (Kreider et al., 2017), the long-term safety data from Antonio & Ciccone (2013), the kidney function analysis by Poortmans & Francaux (2000), and the renal safety study by Gualano et al. (2011). Full citations with DOI links are available in our Research Library.